Ex­perts urge trans­paren­cy, ad­vi­so­ry com­mit­tee re­view for Covid-19 vac­cines

At a vir­tu­al brief­ing on Tues­day, sev­er­al ex­perts told mem­bers of the House Com­mit­tee on Over­sight and Re­form Sub­com­mit­tee on Eco­nom­ic and Con­sumer Pol­i­cy that a trans­par­ent process and ad­vi­so­ry com­mit­tee re­view will be key to the ef­fec­tive roll­out of a vac­cine to pre­vent coro­n­avirus dis­ease.

The brief­ing comes just two weeks af­ter the FDA is­sued guid­ance on the de­vel­op­ment and li­cen­sure of vac­cines against SARS-CoV-2, the virus that caus­es Covid-19, and at a time when some of the most ad­vanced vac­cine can­di­dates are mov­ing in­to Phase 3 tri­als.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER